Screener
Asset Entities ASST Medical Device — Total revenues
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Investment advisory fees | $1,512 | $1,488 |
| Medical device revenues | 1,388 | — |
| Other revenue | 41 | 23 |
| Total revenues | 2,941 | 1,511 |
| Operating expenses: | ||
| Fund management and administration | 1,489 | 1,588 |
| Employee compensation and benefits | 16,314 | 2,005 |
| General and administrative expense | 6,428 | 1,452 |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — total revenues?
- Asset Entities (ASST) reported medical device — total revenues of $1.39M in Q2 2026.
- What does medical device — total revenues mean?
- This metric represents the total gross income generated from the sale of products or services within the specific business segment. It serves as a primary indicator of the segment's market demand and top-line growth performance. Tracking this figure helps investors assess the scale and revenue contribution of this business unit relative to the company's overall operations.
Ask your AI about Asset Entities's medical device — total revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude